Grown Rogue International GRUSF
OTC GRUSF
$0.46 +0.00 (+0.66%)
At close: Aug 19, 2026 · 3:39 PM UTC

Grown Rogue International (GRUSF) Liabilities and Shareholders Equity (2009 - 2026)

Grown Rogue International (GRUSF) posted quarterly Liabilities and Shareholders Equity of $65.8 million for Q1 2026, up 4.95% quarter-over-quarter from $62.7 million in Q4 2025.

Grown Rogue International (GRUSF) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Grown Rogue International's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $65.8 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $65.8 million; the TTM figure through Mar 2026 stood at $55902.6 billion (up 95657570.23% YoY), while the FY2025 annual figure was $62.7 million, changed N/A from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $65.8 million, up from $62.7 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $55902.5 billion in Q3 2025, with the low at $12.3 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $28.1 million (2024), against an average of $6211.4 billion.
  • Peak annual rise in Liabilities and Shareholders Equity reached 184514363.33% in 2025, while the deepest fall reached 184514363.33% in 2025.
  • Grown Rogue International's Liabilities and Shareholders Equity stood at $12.3 million in 2022, then jumped by 76.5% to $21.8 million in 2023, then jumped by 39.27% to $30.3 million in 2024, then surged by 107.07% to $62.7 million in 2025, then grew by 4.95% to $65.8 million in 2026.
  • Business Quant data shows GRUSF's Liabilities and Shareholders Equity at $65.8 million in Q1 2026, $62.7 million in Q4 2025, and $55902.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 6.18 Bn
10 Grown Rogue International 110.47 Mn 98.93 Mn 5.37 Mn 65.02 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 65.02 Mn
Mar 31, 2026 65.84 Mn
Dec 31, 2025 62.74 Mn
Sep 30, 2025 55,902.47 Bn
Sep 30, 2024 30.30 Mn
Jun 30, 2024 28.14 Mn
Dec 31, 2023 21.75 Mn
Jul 31, 2023 20.38 Mn
Jan 31, 2023 18.78 Mn
Oct 31, 2022 12.33 Mn
Apr 30, 2021 8.69 Mn
Jan 31, 2021 5.71 Mn
Oct 31, 2020 3.76 Mn
Jul 31, 2020 4.03 Mn
Apr 30, 2020 3.80 Mn
Jan 31, 2020 3.17 Mn
Oct 31, 2019 2.93 Mn
Jan 31, 2019 6.52 Mn
Oct 31, 2018 5.37 Mn
Aug 31, 2018 25,236.92